1. Home
  2. LOVE vs ABOS Comparison

LOVE vs ABOS Comparison

Compare LOVE & ABOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Lovesac Company

LOVE

The Lovesac Company

N/A

Current Price

$10.85

Market Cap

193.2M

ML Signal

N/A

Logo Acumen Pharmaceuticals Inc.

ABOS

Acumen Pharmaceuticals Inc.

N/A

Current Price

$3.30

Market Cap

155.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LOVE
ABOS
Founded
1998
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Other Specialty Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
193.2M
155.7M
IPO Year
2018
2021

Fundamental Metrics

Financial Performance
Metric
LOVE
ABOS
Price
$10.85
$3.30
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
4
Target Price
$27.60
$7.50
AVG Volume (30 Days)
167.5K
288.9K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$680,628,000.00
N/A
Revenue This Year
$3.68
N/A
Revenue Next Year
$6.34
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.78
$0.86
52 Week High
$21.90
$3.50

Technical Indicators

Market Signals
Indicator
LOVE
ABOS
Relative Strength Index (RSI) 26.48 66.95
Support Level N/A $1.21
Resistance Level $13.76 N/A
Average True Range (ATR) 0.51 0.24
MACD -0.17 0.02
Stochastic Oscillator 8.46 83.67

Price Performance

Historical Comparison
LOVE
ABOS

About LOVE The Lovesac Company

The Lovesac Co designs, manufactures and sells alternative furniture which is comprised of modular couches called sactionals and premium foam beanbag chairs called sacs. It also offers other accessories such as sactional-specific drink holders, Footsac blankets, decorative pillows, fitted seat tables, and ottomans. Its products are sold across the United States through its website or company-owned retail stores which are used in homes and offices. The majority of the firm's revenue is derived from the sale of Sactionals.

About ABOS Acumen Pharmaceuticals Inc.

Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.

Share on Social Networks: